Literature DB >> 26854038

Neonatal Risk Factors for Treatment-Demanding Retinopathy of Prematurity: A Danish National Study.

Carina Slidsborg1, Aksel Jensen2, Julie Lyng Forman3, Steen Rasmussen4, Regitze Bangsgaard5, Hans Callø Fledelius5, Gorm Greisen6, Morten la Cour5.   

Abstract

PURPOSE: One goal of the study was to identify "new" statistically independent risk factors for treatment-demanding retinopathy of prematurity (ROP). Another goal was to evaluate whether any new risk factors could explain the increase in the incidence of treatment-demanding ROP over time in Denmark.
DESIGN: A retrospective, register-based cohort study. PARTICIPANTS: The study included premature infants (n = 6490) born in Denmark from 1997 to 2008.
METHODS: The study sample and the 31 candidate risk factors were identified in 3 national registers. Data were linked through a unique civil registration number. Each of the 31 candidate risk factors were evaluated in univariate analyses, while adjusted for known risk factors (i.e., gestational age [GA] at delivery, small for gestational age [SGA], multiple births, and male sex). Significant outcomes were analyzed thereafter in a backward selection multiple logistic regression model. MAIN OUTCOME MEASURES: Treatment-demanding ROP and its associations to candidate risk factors.
RESULTS: Mechanical ventilation (odds ratio [OR], 2.84; 95% confidence interval [CI], 1.99-4.08; P < 0.01) and blood transfusion (OR, 1.97; 95% CI, 1.20-3.14; P = 0.01) were the only new statistically independent risk factors, in addition to GA at delivery, SGA, multiple births, and male sex. Modification in these prognostic factors for ROP did not cause an increase in treatment-demanding ROP.
CONCLUSIONS: In a large study population, blood transfusion and mechanical ventilation were the only new statistically independent risk factors to predict the development of treatment-demanding ROP. Modification in the neonatal treatment with mechanical ventilation or blood transfusion did not cause the observed increase in the incidence of preterm infants with treatment-demanding ROP during a recent birth period (2003-2008).
Copyright © 2016 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26854038     DOI: 10.1016/j.ophtha.2015.12.019

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  24 in total

1.  N-terminal B-type natriuretic peptide urinary concentrations and retinopathy of prematurity.

Authors:  Christoph Bührer; Ömer Erdeve; Anton van Kaam; Angelika Berger; Evelyn Lechner; Benjamin Bar-Oz; Karel Allegaert; Tom Stiris; İstemi Han Çelik; Janet Berrington
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

2.  Antenatal exposure to fenoterol is not associated with the development of retinopathy of prematurity in infants born before 32 weeks of gestation.

Authors:  Hannes Hudalla; Thomas Bruckner; Johannes Pöschl; Thomas Strowitzki; Ruben-J Kuon
Journal:  Arch Gynecol Obstet       Date:  2020-02-28       Impact factor: 2.344

3.  [Screening for retinopathy of prematurity: Trends over the past 5 years in two German university hospitals].

Authors:  P P Larsen; M-C Bründer; M Petrak; V Jehle; W A Lagrèze; F G Holz; A Stahl; T U Krohne
Journal:  Ophthalmologe       Date:  2018-06       Impact factor: 1.059

Review 4.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

Review 5.  Retinopathy of prematurity: contribution of inflammatory and genetic factors.

Authors:  Mariza Fevereiro-Martins; Hercília Guimarães; Carlos Marques-Neves; Manuel Bicho
Journal:  Mol Cell Biochem       Date:  2022-03-09       Impact factor: 3.396

6.  Pre-eclampsia and the risk of retinopathy of prematurity in preterm infants with birth weight <1500 g and/or <31 weeks' gestation.

Authors:  Belal Alshaikh; Omar Salman; Nancy Soliman; Anna Ells; Kamran Yusuf
Journal:  BMJ Open Ophthalmol       Date:  2017-06-19

7.  Risk Factors Associated with Retinopathy of Prematurity in Very and Extremely Preterm Infants.

Authors:  Claudia Ioana Borțea; Florina Stoica; Marioara Boia; Emil Radu Iacob; Mihai Dinu; Roxana Iacob; Daniela Iacob
Journal:  Medicina (Kaunas)       Date:  2021-04-27       Impact factor: 2.430

8.  Refining evidence-based retinopathy of prematurity screening guidelines: The SCREENROP study.

Authors:  Kourosh Sabri; Sandesh Shivananda; Forough Farrokhyar; Alessandro Selvitella; Bethany Easterbrook B Kin; Wendy Seidlitz; Shoo K Lee
Journal:  Paediatr Child Health       Date:  2019-08-12       Impact factor: 2.253

9.  Higher or Lower Hemoglobin Transfusion Thresholds for Preterm Infants.

Authors:  Haresh Kirpalani; Edward F Bell; Susan R Hintz; Sylvia Tan; Barbara Schmidt; Aasma S Chaudhary; Karen J Johnson; Margaret M Crawford; Jamie E Newman; Betty R Vohr; Waldemar A Carlo; Carl T D'Angio; Kathleen A Kennedy; Robin K Ohls; Brenda B Poindexter; Kurt Schibler; Robin K Whyte; John A Widness; John A F Zupancic; Myra H Wyckoff; William E Truog; Michele C Walsh; Valerie Y Chock; Abbot R Laptook; Gregory M Sokol; Bradley A Yoder; Ravi M Patel; C Michael Cotten; Melissa F Carmen; Uday Devaskar; Sanjay Chawla; Ruth Seabrook; Rosemary D Higgins; Abhik Das
Journal:  N Engl J Med       Date:  2020-12-31       Impact factor: 176.079

10.  Effects of Liberal vs Restrictive Transfusion Thresholds on Survival and Neurocognitive Outcomes in Extremely Low-Birth-Weight Infants: The ETTNO Randomized Clinical Trial.

Authors:  Axel R Franz; Corinna Engel; Dirk Bassler; Mario Rüdiger; Ulrich H Thome; Rolf F Maier; Ingeborg Krägeloh-Mann; Martina Kron; Jochen Essers; Christoph Bührer; Georg Rellensmann; Rainer Rossi; Hans-Jörg Bittrich; Claudia Roll; Thomas Höhn; Harald Ehrhardt; Stefan Avenarius; Hans Thorsten Körner; Anja Stein; Horst Buxmann; Matthias Vochem; Christian F Poets
Journal:  JAMA       Date:  2020-08-11       Impact factor: 157.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.